BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35304835)

  • 1. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
    Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
    Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of delaying colonoscopies during the COVID-19 pandemic on colorectal cancer detection and prevention.
    Holland J; Cwintal M; Rigas G; Pang AJ; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
    Surg Endosc; 2022 Dec; 36(12):9364-9373. PubMed ID: 35428894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Cervical and Colorectal Cancer Screenings During the Pandemic in Community Health Centers: Practice Changes and Recovery Strategies.
    Huguet N; Danna M; Baron A; Hall J; Hodes T; O'Malley J; Holderness H; Marino M; DeVoe JE; Cohen DJ
    Med Care; 2023 Aug; 61(8):554-561. PubMed ID: 37310241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.
    El Bizri M; Hamidi MW; Mksyartinian P; Stein BD
    Curr Oncol; 2023 Oct; 30(10):8973-8991. PubMed ID: 37887548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
    JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
    Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
    Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience.
    Castonguay M; El Sayed R; Richard C; Vachon MF; Nassabein R; Charpentier D; Tehfé M
    Curr Oncol; 2022 May; 29(5):3282-3290. PubMed ID: 35621658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
    Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
    Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
    Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
    J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
    Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
    JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.